HopeStage
Back to all studies
RecruitingNCT06467474

Group psychoeducation added to usual care for depression

About this titleRead the official source — NCT06467474
Medication studyAges 18–59Brazil
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 59 years.

Listed locations
São PauloSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
338
Sponsor
Ricardo Alberto Moreno, M.D., Ph.D.
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural, Drug
Locations
Brazil
Age range
From 18 Years to 59 Years
Official registry ID
NCT06467474
Official title
Show the full official title

Psychoeducation for Major Depressive Disorder: Development and Evaluation of Effectiveness

Recruitment & locations

Currently recruiting

São Paulo

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ricardo Alberto Moreno, M.D., Ph.D.

Does this study involve medication?

Yes. The study involves medication, including TAU.

Who can participate?

Listed age limits: 18 years to 59 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies